VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023InvestorPlace • about 1 month ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
VINC stock results show that Vincerx Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
The post VINC...
Share to Feed
Vincerx to also provide update on pipeline progress, including for VIP943 programPALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical...
Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06...
Comparing Vincerx Pharma's Performance Against Analyst EstimatesRelated Stocks: VINC...
VIP236, first-in-class small molecule-drug conjugate (SMDC), preliminary Phase 1 data and update on pipeline progress will be presented by management at a virtual investor event on April 8 at 2:00 PM...
Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...